StocksMedium•5 November 2026•
1 min read
Lexicon Pharmaceuticals Q3 Loss Narrower Than Estimated
Key Facts
1Lexicon Pharmaceuticals reported a quarterly loss of $0.03 per share, narrower than the estimated loss of $0.06.
2The company's revenue for the third quarter of 2026 exceeded analyst estimates.
Lexicon Pharmaceuticals reported a quarterly loss of $0.03 per share, which was narrower than the estimated loss of $0.06. According to Zacks, the company's revenue for the third quarter of 2026 exceeded analyst estimates, driven by better-than-anticipated operational performance during the fiscal period.
LXRX closed at $1.48 on November 4, 2026, with the stock trading between a day low of $1.46 and a day high of $1.54 during that session.